GE HealthCare unveils AI-powered Invenia ABUS Premium for dense breast screening
GE HealthCare has launched Invenia ABUS Premium, an advanced 3D ultrasound system designed to enhance breast cancer screening in women with dense breast tissue. The technology, which received Premarket Approval from the US Food and Drug Administration, incorporates artificial intelligence to accelerate scanning times and improve image quality.